糖尿病之友2023,Issue(3) :17-18.

间苯三酚联合曲马多治疗痉挛性腹痛的临床研究

王敏
糖尿病之友2023,Issue(3) :17-18.

间苯三酚联合曲马多治疗痉挛性腹痛的临床研究

王敏1
扫码查看

作者信息

  • 1. 临清市人民医院内科,山东 临清 252600
  • 折叠

摘要

目的:探究在痉挛性腹痛的治疗中,联合应用间苯三酚与曲马多的临床疗效。方法:筛选2021年5月—2022年10月以来,由我院接收并实施诊疗的痉挛性腹痛患者178例作为参与者纳入本次研究。分组标准以掷骰子方式为准,将其分成两组,对照组79例,观察组79例。结果:对照组总有效率86.08%,观察组则为97.47%,组间比较,观察组的有效率更高,临床疗效更为理想;对照组总满意度89.87%,观察组则为98.73%,组间比较,观察组患者的满意度更高;实施不同的治疗方法后,对照组共计发生13例不良反应,占比16.46

Abstract

Objective:To explore the clinical efficacy of phloroglucinol combined with tramadol in the treatment of spastic abdominal pain.Methods:A total of 178 patients with spastic abdominal pain admitted and treated in our hospital from May 2021 to October 2022 were selected as participants in this study.They were divided into two groups,79 cases in the control group and 79 cases in the observation group.Results:The total effective rate of the control group was 86.08%,and that of the observation group was 97.47%.Compared between groups,the effective rate of the observation group was higher and the clinical efficacy was more ideal.The total satisfaction of the control group was 89.87%,and that of the observation group was 98.73%.Compared between groups,the satisfaction of the observation group was higher.After the implementation of different treatment methods,a total of 13 cases of adverse reactions occurred in the control group,accounting for 16.46%,and 3 cases occurred in the observation group,accounting for 3.80%.Compared between groups,the incidence rate of adverse reactions in the observation group was lower,and the safety of therapy was higher.Conclusion:The combination of phloroglucinol and Tramadol in the treatment of spastic abdominal pain has significant clinical efficacy and high safety,which is worth recommending in a wide range.

关键词

间苯三酚/曲马多/痉挛性腹痛/临床疗效

Key words

phloroglucinol/Tramadol/Spastic abdominal pain/Clinical effect

引用本文复制引用

出版年

2023
糖尿病之友
中南大学湘雅二医院 解放军第三零六医院

糖尿病之友

影响因子:0.001
ISSN:1671-3486
参考文献量8
段落导航相关论文